Double-blind trial of bestatin in HIV-positive patients

M Hørding; P C Gøtzsche; L Dalh Christensen; Ib Christian Bygbjerg; V Faber

Double-blind trial of bestatin in HIV-positive patients

M Hørding, P C Gøtzsche, L Dalh Christensen, Ib Christian Bygbjerg, V Faber

Department of Immunology and Microbiology

4 Citations (Scopus)

Abstract

Twenty-two HIV-positive homosexual men with a moderately impaired immune system were randomized to bestatin capsules 60 mg a day or placebo for 4 weeks. None suffered from opportunistic infections. The immunomodulating effect of bestatin was investigated by lymphocyte proliferation assay with pokeweed mitogen, phytohaemagglutinin, and concanavalin A, surface marker analysis of T-helper/T-suppressor cells by flow cytometry, natural killer cell activity, beta-2-microglobulin and HIV antibody quantitation. No significant differences between bestatin and placebo in immunological, haematological, biochemical or clinical variables were detected.

Original language	English
Journal	Biomedicine & Pharmacotherapy
Volume	44
Issue number	9
Pages (from-to)	475-8
Number of pages	4
ISSN	0753-3322
Publication status	Published - 1 Jan 1990

Keywords

Adjuvants, Immunologic
Aminopeptidases
Double-Blind Method
HIV Infections
HIV Seropositivity
Humans
Leucine
Male

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{5ee481e66f2447219a14e88baaecd0c3,

title = "Double-blind trial of bestatin in HIV-positive patients",

abstract = "Twenty-two HIV-positive homosexual men with a moderately impaired immune system were randomized to bestatin capsules 60 mg a day or placebo for 4 weeks. None suffered from opportunistic infections. The immunomodulating effect of bestatin was investigated by lymphocyte proliferation assay with pokeweed mitogen, phytohaemagglutinin, and concanavalin A, surface marker analysis of T-helper/T-suppressor cells by flow cytometry, natural killer cell activity, beta-2-microglobulin and HIV antibody quantitation. No significant differences between bestatin and placebo in immunological, haematological, biochemical or clinical variables were detected.",

keywords = "Adjuvants, Immunologic, Aminopeptidases, Double-Blind Method, HIV Infections, HIV Seropositivity, Humans, Leucine, Male",

author = "M H{\o}rding and G{\o}tzsche, {P C} and {Dalh Christensen}, L and Bygbjerg, {Ib Christian} and V Faber",

year = "1990",

month = jan,

day = "1",

language = "English",

volume = "44",

pages = "475--8",

journal = "Biomedicine and Pharmacotherapy",

issn = "0753-3322",

publisher = "Elsevier Masson",

number = "9",

}

TY - JOUR

T1 - Double-blind trial of bestatin in HIV-positive patients

AU - Hørding, M

AU - Gøtzsche, P C

AU - Dalh Christensen, L

AU - Bygbjerg, Ib Christian

AU - Faber, V

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Twenty-two HIV-positive homosexual men with a moderately impaired immune system were randomized to bestatin capsules 60 mg a day or placebo for 4 weeks. None suffered from opportunistic infections. The immunomodulating effect of bestatin was investigated by lymphocyte proliferation assay with pokeweed mitogen, phytohaemagglutinin, and concanavalin A, surface marker analysis of T-helper/T-suppressor cells by flow cytometry, natural killer cell activity, beta-2-microglobulin and HIV antibody quantitation. No significant differences between bestatin and placebo in immunological, haematological, biochemical or clinical variables were detected.

AB - Twenty-two HIV-positive homosexual men with a moderately impaired immune system were randomized to bestatin capsules 60 mg a day or placebo for 4 weeks. None suffered from opportunistic infections. The immunomodulating effect of bestatin was investigated by lymphocyte proliferation assay with pokeweed mitogen, phytohaemagglutinin, and concanavalin A, surface marker analysis of T-helper/T-suppressor cells by flow cytometry, natural killer cell activity, beta-2-microglobulin and HIV antibody quantitation. No significant differences between bestatin and placebo in immunological, haematological, biochemical or clinical variables were detected.

KW - Adjuvants, Immunologic

KW - Aminopeptidases

KW - Double-Blind Method

KW - HIV Infections

KW - HIV Seropositivity

KW - Humans

KW - Leucine

KW - Male

M3 - Journal article

C2 - 2081275

SN - 0753-3322

VL - 44

SP - 475

EP - 478

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

IS - 9

ER -

Double-blind trial of bestatin in HIV-positive patients

Abstract

Keywords

UN SDGs

Fingerprint

Cite this